Anti-endothelial cell antibodies and biopsyproven temporal arteritis

Lupus

Volumn 11, Issue 2, 2002, Pages 134-

  Amor Dorado, J C ^a   Garcia Porrua C ^a   Gonzalez Gay, M A ^a  

^a Divisions of Rheumatology and Otolaryngology of the Hospital Xeral Calde   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIBODY; ENDOTHELIAL CELL ANTIBODY; UNCLASSIFIED DRUG;

BIOPSY; BLOOD VESSEL INJURY; CLINICAL FEATURE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC ANALYSIS; HUMAN; IMMUNOFLUORESCENCE; LETTER; PRIORITY JOURNAL; TEMPORAL ARTERITIS;

AUTOANTIBODIES; BIOLOGICAL MARKERS; BIOPSY; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; REPRODUCIBILITY OF RESULTS; SPAIN; TEMPORAL ARTERITIS;

EID: 18344365574     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203302lu168xx     Document Type: Letter

References (6)

1. Anti-endothelial cell antibodies in systemic autoimmune diseases: Prevalence and clinical significance
2. Rheumatic disease sera reactive with capillaries in the mouse kidney
3. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association
4. Polymyalgia rheumatica: A syndrome associated with HLA-DR4 antigen
5. Antiendothelial cell antibodies: A need for standardization
6. A need for standardization of the anti-endothelial-cell antibody test